NUE
34
-6
AVY
37
-7
MSI
44
-6
IVZ
43
4
FOX
70
6
FE
44
7
IBM
44
-6
NFLX
61
-4
R
54
-5
PVH
52
-5
CMCSA
37
-9
AON
30
-2
CTSH
44
-3
SCHW
43
7
KMB
31
3
CTAS
36
-4
SJM
24
7
FIS
50
7
URI
28
-8
WY
31
-8
NUE
34
-6
AVY
37
-7
MSI
44
-6
IVZ
43
4
FOX
70
6
FE
44
7
IBM
44
-6
NFLX
61
-4
R
54
-5
PVH
52
-5
CMCSA
37
-9
AON
30
-2
CTSH
44
-3
SCHW
43
7
KMB
31
3
CTAS
36
-4
SJM
24
7
FIS
50
7
URI
28
-8
WY
31
-8
Financhill
Back

FlexShares Credit-Scored US Corp Bond Index Fund Vs. Bright Minds Biosciences Industry Stock Comparison

Sell
40

SKOR
FlexShares Credit-Scored US Corp Bond Index Fund

Last Price:
$47.71
Seasonality Move:
-0.44%
Sell
47

DRUG
Bright Minds Biosciences

Last Price:
$39.35
Seasonality Move:
-32.13%
Sell
40
FlexShares Credit-Scored US Corp Bond Index Fund (SKOR) is a Sell

Is FlexShares Credit-Scored US Corp Bond Index Fund a Buy, Sell or Hold?

  • The current FlexShares Credit-Scored US Corp Bond Index Fund [SKOR] share price is $47.71. The Score for SKOR is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • SKOR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $41.11. The Score for DRUG is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SKOR Stock Price Chart

What is FlexShares Credit-Scored US Corp Bond Index Fund's stock price today?

  • The FlexShares Credit-Scored US Corp Bond Index Fund share price today is $47.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SKOR is experiencing slight selling pressure.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $41.11
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

SKOR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 37.26 Sell
Chaikin Money Flow: -3297 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.78 - 48.34) Sell
Bollinger Bands (100): (48.02 - 48.88) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 54.62 Buy
Chaikin Money Flow: 95650 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.14 - 42.26) Buy
Bollinger Bands (100): (2.79 - 43.87) Buy

SKOR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.69 Buy
20-day SMA: 48.01 Sell
50-day SMA: 48.1 Sell
200-day SMA: 47.97 Sell
8-day EMA: 47.75 Sell
20-day EMA: 47.91 Sell
50-day EMA: 48.11 Sell
200-day EMA: 48 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.62 Buy
20-day SMA: 38.93 Buy
50-day SMA: 41.93 Sell
200-day SMA: 12.23 Buy
8-day EMA: 38.76 Buy
20-day EMA: 39.01 Buy
50-day EMA: 35.89 Buy
200-day EMA: 18.21 Buy

FlexShares Credit-Scored US Corp Bond Index Fund Earnings Growth & SKOR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

FlexShares Credit-Scored US Corp Bond Index Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):